Management

Thomas M. Fitzgerald
CEO

25 years of BioPharma experience as Senior Executive with SmithKlineBeecham, Fisons, Aventis, Sheffield Pharma.

Douglas Naab
VP, Business Development & Licensing

15 years experience as a senior business development and licensing executive for a variety of companies including IPValue, Xerox and Integument Technologies. Expertise in the strategic management of patents and technology, as well as deal structure and negotiation.

W. Timothy Bibens
Director of Operations

Product development professional with 20 + years experience with Clinical Chemistry, Class III medical devices and critical aerospace safety and navigation products. Expert in developing operational capabilities in support of high criticality products.

Joel Wojciechowski, Ph.D.
Director of Preclinical Development

Doctoral and postdoctoral studies in cell adhesion and microcirculation in vitro and in vivo. Previous Wall Street experience.

Board of Directors

Thomas M. Fitzgerald

Michael L. Weiner

Ricardo Mesa-Tejada, M.D.

Scientific Advisory Board

Michael King, Ph.D.

Jane Liesveld, M.D.

Alan Smith, Ph.D.

David Schaffer, Ph.D.